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Abstract
Streptolysin S (SLS) is a bacteriocin-like haemolytic and cytotoxic virulence factor that plays a key role in the virulence of
Group A Streptococcus (GAS), the causative agent of pharyngitis, impetigo, necrotizing fasciitis and streptococcal toxic shock
syndrome. Although it has long been thought that SLS and related peptides are produced by GAS and related streptococci
only, there is evidence to suggest that a number of the most notorious Gram-positive pathogenic bacteria, including Listeria
monocytogenes, Clostridium botulinum and Staphylococcus aureus, produce related peptides. The distribution of the L.
monocytogenes cluster is particularly noteworthy in that it is found exclusively among a subset of lineage I strains; i.e., those
responsible for the majority of outbreaks of listeriosis. Expression of these genes results in the production of a haemolytic
and cytotoxic factor, designated Listeriolysin S, which contributes to virulence of the pathogen as assessed by murine- and
human polymorphonuclear neutrophil–based studies. Thus, in the process of establishing the existence of an extended
family of SLS-like modified virulence peptides (MVPs), the genetic basis for the enhanced virulence of a proportion of
lineage I L. monocytogenes may have been revealed.
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Introduction
Bacteriocins are ribosomally synthesized antibacterial peptides
of bacterial origin that have been the focus of much attention since
their discovery over 70 years ago. The Class I lantibiotics have
been of particular interest, given the unusual post-translational
modifications which are required for their activity [1–3]. Most
modified bacteriocins have been investigated with a view to their
potential applications in medicine or food, but there are two
exceptional examples of bacteriocin-like modified peptides that are
cytotoxic and which contribute to the virulence of bacterial
pathogens; i.e. the lantibiotic Cytolysin (Enterococcus faecalis) [4] and
Streptolysin S (Group A Streptococcus; i.e. GAS) [5]. Streptolysin S
(SLS) production is particularly significant as it contributes to the
cytotoxicity, inflammatory activation and polymorphonuclear
neutrophil (PMN) resistance of GAS, thereby playing a role in
necrosis and systemic spread [6]. It is also responsible for the
associated characteristic b-haemolytic activity. The structure of the
SLS peptide has not been elucidated and it was only following
identification of the associated genetic determinants that it was
realised that SLS is a post-translationally modified bacteriocin-like
peptide [7]. More specifically, analysis of the SLS-associated genes
(sag; Streptolysin S associated genes) indicates that the structural
peptide (encoded by sagA) is extraordinarily rich in cysteines (Cys),
glycines (Gly) and hydroxylated amino acids (Fig. 1). It has been
established that post-translational modifications occur that result
in the formation of thiazole and oxazole residues (or heterocycles)
[5,7,8] in a manner analogous to that associated with the
bacteriocin microcin B17 (Mcb) [9]. A number of other proteins
which are essential for SLS production [5] are also typical of those
associated with bacteriocin biosynthesis or immunity, including
most notably SagB, which is homologous to the oxidoreductase
McbC required for the post-translational modification of microcin
B17 [10]. Indeed, it has been established that SLS biosynthetic
enzymes, SagBCD, function in a manner analogous to the
microcin B17 modification machinery, McbBCD, as SagBCD
can substitute for McbBCD with respect to modification of the
microcin B17 structural peptide in vitro [8].
It had been thought for some time that SLS-like virulence
factors are exclusively associated with streptococci (related
peptides are produced by group C and G streptococci and
Streptococcus iniae) [6]. In silico analysis demonstrates that gene
clusters potentially encoding Sls-like factors are also present in
some of the most notorious Gram positive pathogens, including
Listeria monocytogenes, Staphylococcus aureus and Clostridium botulinum.A
specific focus on the L. monocytogenes cluster has revealed that it
encodes an inducible cytotoxic and haemolytic peptide, Lister-
iolysin S, which plays a role in the survival of the pathogen in
PMNs and contributes to its virulence in the mouse model.
Notably, the Listeriolysin S-associated cluster is strain variable,
PLoS Pathogens | www.plospathogens.org 1 September 2008 | Volume 4 | Issue 9 | e1000144being present in a subset of isolates from lineage I, the evolutionary
lineage associated with the majority of epidemics associated with
this often fatal pathogen.
Results
In silico screen for novel SLS-like factors
Previous in-silico investigations have successfully identified
producers of novel post-translationally modified lantibiotics by
screening for the presence of associated genes which are likely to
be highly conserved; i.e. those encoding proteins that are involved
in post-translational modifications [11,12]. We used a similar
approach to identify novel producers of SLS-like peptides,
searching for homologues of sagB, the gene encoding the McbC-
like oxidoreductase associated with heterocycle formation [7]. This
revealed that SagB-related proteins are potentially produced by a
number of L. monocytogenes strains (including the genome-sequenced
strains F2365 (NC_002973) and H7858 (NZ_AADR00000000)),
by S. aureus ET3-1 (a representative of the most abundant bovine
mastitis-associated S. aureus lineages (NC_007622)), and by a
number of group I Clostridium botulinum strains (ATCC3502/Hall
(NC_009495), ATCC19397 (NC_009697) and Langeland
(NC_009699)). In each case the SagB homolog is located in a
cluster of additional sag homologues. This fact has also been
recently noted by Lee et al [8]. Notably, each of these clusters
contains a gene capable of encoding a SLS-like peptide (which we
designate Listeriolysin S (LLS), Stapholysin S (STS) and Botulysin
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Figure 1. Comparison of MVP-associated operons. Arrangement of the Stapholysin S (sts), Listeriolysin S (lls), Streptolysin S (sag) and Botulysin
(bts) associated genes in S. aureus ET3-1, L. monocytogenes F2365, S. pyogenes MGAS 8232 and C. botulinum ATCC3502 respectively. Homology
between the predicted lls gene products and their sag and sts equivalents is indicated by a line and dashed line, respectively, with an associated %
identity value. % identity values with respect to the predicted Sag and Bts gene products are also indicated. The amino acid sequence of the
predicted unmodified structural peptides, StsA, LlsA, SagA and BtsA is presented (boxed) with italicized letters indicating amino acids likely to
constitute the leader region. Residues within the structural propeptide that are potentially modified are underlined. The location of oligonucleotide
pairs used to investigate strain variation are indicated (i) llsAint-llsAsoeD, (ii) 1118degf–1118degr and (iii) 1118f–1118r.
doi:10.1371/journal.ppat.1000144.g001
Author Summary
Listeria monocytogenes is known to produce only one
haemolytic factor that plays an important role in its
pathogenic cycle—that is, the cholesterol-dependent
Listeriolysin O. However, here we identify a second
haemolysin, which is present in a subset of strains of
lineage I, the evolutionary lineage of L. monocytogenes that
contributes to the majority of spontaneous and epidemic
outbreaks of listeriosis. This second haemolysin is only
induced under oxidative stress conditions and contributes
to murine virulence and in survival in polymorphonuclear
neutrophils. Bioinformatic analysis suggests that the
haemolysin Listeriolysin S (LLS) is post-translationally
modified and belongs to a family of modified virulence
peptides, including the potent virulence factor Streptolysin
S (SLS), a peptide cytolysin produced by Streptococcus
pyogenes, and several as-yet uncharacterised members of
the same family in other pathogens. Therefore, en route to
establishing that some L. monocytogenes produce more
than one haemolysin, we have uncovered a virulence
factor that is exclusively associated with a subset of the
lineage I evolutionary line and that is also the first non-
streptococcal representative of a potentially extended
family of SLS-like peptides.
A Novel L. monocytogenes Haemolysin
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all encode a peptide consisting of a leader region that terminates
with the classical ‘double glycine’ bacteriocin-associated leader
cleavage motif [13] and a putative pro-peptide with an extreme
predominance of cysteine, serine, threonine and, in the case of
BTS (and SLS), glycine residues (Fig. 1), all of which are residues
involved in heterocycle modification. Notably, the presence of llsA
in genome-sequenced L. monocytogenes has been overlooked during
annotation of the relevant genomes. It should be noted that it
contrast to the depiction by Lee et al. [8], llsA is the first gene
within the LLS cluster. Examination of the clusters in greater
depth establishes two subgroups consisting of the BTS/SLS and
LLS/STS gene clusters (Fig. 1). In the case of the eight lls genes,
only llsX does not have significant identity with its sts equivalent,
while both llsB and llsY are represented by two ORFs in the Sts
gene cluster (Fig. 1). Our re-sequencing of this region in S. aureus
ET3-1 has confirmed that these ORFs are not an artefact from
genome sequencing of ET3-1. On the basis of genome
dissimilarity values and GC content analysis (Table S1), the lls
and sts genes also differ from their sls and bts counterparts in that
they appear to have been acquired by horizontal gene transfer.
We conducted a more in-depth analysis of the LLS gene cluster
since it was found in L. monocytogenes F2365 and H7858, two strains
responsible for epidemic outbreaks of listeriosis (a life-threatening
infection of pregnant and immuno-compromised humans [14]).
We named the cluster Listeria pathogenicity island 3 (LIPI-3), in
order to distinguish it from LIPI-1, present in all pathogenic L.
monocytogenes and containing many of the well established virulence
factors associated with pathogenesis [15], and LIPI-2, a pathoge-
nicity island found exclusively in the ruminant pathogen L. ivanovii
[16]. LIPI-3 is flanked by Rho-independent terminators and two
related glyoxalase-encoding genes (lmof2365_1111 and
lmof2365_1121; 81% identity). The predicted llsA promoter (PllsA)
does not contain any of the motifs previously associated with
virulence gene regulation in other L. monocytogenes strains (e.g., a
PrfA box or a s
B binding site). In addition to LlsA and LlsB
(24.7% identity with SagB), other proteins encoded by LIPI-3
include LlsGH, two components of an ABC transporter (22.4%
and 19.8% identical to SagGH, respectively), LlsD (24.7% identity
with SagD) and LlsP, which has been annotated as an N-terminal
protease (frequently associated with bacteriocin leader cleavage).
Given their location within this region, llsX and llsY are also likely
to be relevant (Fig. 1).
Investigation of the distribution of LIPI-3 in L.
monocytogenes
L. monocytogenes strains can be divided into three evolutionary
lineages, I, II and III [17]. Despite the fact that strains of all
lineages possess the well established virulence factors associated
with the LIPI-1 pathogenicity island [18], lineage I (which consists
of strains of serotype 1/2b and the notorious serotype 4b) is most
frequently associated with outbreaks and sporadic cases of human
listeriosis [19]. However, to date, no additional virulence factor
has been specifically associated with lineage I. We carried out
additional in silico analysis of genome-sequenced Listeria which
revealed that although the lineage I strains F2365 and H7858
possess LIPI-3, it is absent from the genome-sequenced strains
EGDe [20], F6854 [21] (both lineage II), and the non-pathogenic
L. innocua CLIP 11262 [20] and L. welshimeri SLCC5334 [22]
(Fig. 2). These investigations also highlighted the variable nature of
this region of L. monocytogenes genomes. For instance, H7858
possesses an additional 14 ORFs immediately upstream of its
LIPI-3 equivalent, while there is a large amount of inserted DNA
(.17 kB) in place of LIPI-3 in EGDe (Fig. 2). Analysis of the
corresponding regions from recently released sequence data from a
number of L. monocytogenes strains generated by the Broad Institute
emphasises the genetic variability at this locus ([23]; Fig. 2). Such
analysis also reveals that homologs of the up- and downstream
genes (lmof2365_1111 and lmof2365_1120) are found in some
LIPI-3
2 strains, thereby confirming that the flanking Rho-
independent terminators mark the outer limits of LIPI-3 (Fig. 2).
To better assess the strain variable nature of the island, we
examined additional Listeria isolates representing a cross-section of
all three lineages, as well as other Listeria species. These revealed
that LIPI-3 is consistently absent from all lineage II and III L.
monocytogenes and from all other species tested (L. innocua, L.
welshimeri, L. seeligeri, L. ivanovii, and L. grayi) (Table S2). LIPI-3 is
also absent from some lineage I strains; of those tested
approximately half possess the island (52% positive; 23/44 strains)
(Table S3). The LIPI-3
+ strains corresponded to representatives of
13 of the 19 lineage I sequence types (STs) [24] previously
proposed (i.e. STs 3–10, 13–14 and 17–19). In addition to F2365
and H7858, responsible for epidemic outbreaks of listeriosis in
California (1985) and the US (multistate; 1998–99), respectively,
the LIPI-3
+ set includes the listeriosis-outbreak strains from
Halifax (1981), Lausanne (1987), Illinois (1994) and North
Carolina (2000) (Fig. 3; Table S3). In contrast, relatively few
lineage I outbreak-associated strains (Massachusetts 1985, UK
1989) lack LIPI-3 (Fig. 3; Table S3). When the LIPI-3 status of the
lineage I strains is mapped onto the phylogenetic tree (maximum
parsimony tree inferred from combined sequence data) which
revealed the presence of the 19 lineage 1 STs [24], it was apparent
that although the presence/absence of the island is consistent
within individual STs, there are variations within major branches
(Fig. 3). This observation is consistent with repeated independent
acquisition or loss of LIPI-3. While %GC content and genome
dissimilarity values indicate that LIPI-3 has been acquired, this is
more likely to have been an event in an ancestral lineage I strain.
Therefore the variable nature of LIPI-3 within lineage I is more
likely to reflect its loss within specific sequence types (most likely as
a consequence of recombination between lmof2365_1111 and
lmof2365_1121 and looping out of intervening genes). This would
represent a recurring theme in Listeria evolution as the emergence
of non-pathogenic Listeria species has been attributed to the loss of
LIPI-1 from the primordial species [25].
LIPI-3 encodes a haemolytic and cytotoxic factor
Since SLS is responsible for the haemolytic activity of GAS, we
looked for an association between the presence of LIPI-3 and
haemolysis. All L. monocytogenes lineages produce the haemolysin
Listeriolysin O (a 60 kDa protein encoded by hly located within
LIPI-1) [15,26–28] which would be expected to mask any
haemolytic activity associated with LLS. Therefore, a Dhly mutant
of F2365 was created. However, this mutant is non-haemolytic on
Columbia blood agar (Fig. 4A). To determine whether the lls genes
are expressed under these conditions, the Lls promoter (PllsA) was
fused to a Lux reporter system in a promoter probe vector
(pPLKm2) and integrated as a single copy into the F2365 genome.
Real-time analysis with an IVIS100 imager (Xenogen) revealed that
under routine laboratory growth conditions expression of Lux is
negligible, but that the promoter was strongly induced upon
exposure for 10 min to oxidative stress, including cumene hydrogen
peroxide and hydrogen peroxide (Fig. 5). The induction is transient,
dissipating gradually over a 60 min period. Unfortunately, the
requirement for cumene or hydrogen peroxide induction prevents
an assessment of any associated haemolytic and/or cytotoxic
activities. To overcome this problem, a constitutively strong
synthetic Gram positive promoter, PHELP [29], was introduced
A Novel L. monocytogenes Haemolysin
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the genes under the control of PHELP significantly enhanced the
haemolytic activity of F2365 (F2365LLS
C) and also resulted in a
haemolytic phenotype against the Dhly background (i.e.
F2365LLS
CDhly) (Fig. 4A). This haemolytic activity was eliminated
when llsB, predicted to be necessary for the production of mature,
active LLS, was mutated in a non-polar fashion
(F2365LLS
CDhlyDllsB), confirming the link between the LIPI-3
island and the haemolytic phenotype (Fig. 4A). L. monocytogenes cells
were used in haemolytic assays as it was apparent that LLS, like
SLS, is active in a cell-associated form with no haemolytic activity
evident from cell-free culture supernatant. Constitutive expression
of LLS also resulted in enhanced cytotoxicity as, F2365LLS
CDhly
was significantly more cytotoxic than F2365Dhly against C2-Bbe
(human enterocyte-like), J774 (mouse macrophage) and CT26
(mouse colon carcinoma) cell lines (Fig. 4B).
One of the intriguing features of SLS is that although it is active
when cell associated, it is inactive in cell-free situations unless it is
activated by an inducer such as RNA core (ribonuclease-resistant
fraction of yeast RNA) in a suitable buffer (RNA
C) [30,31]. Our
analysis of cell-free supernatant (CFS) from F2365LLS
CDhly and
F2365LLS
CDhlyDllsB cultures established that both lacked hae-
molytic activity (Fig. 4C). However, as with SLS-producers [31],
when the LLS-producing cell (F2365LLS
CDhly) were washed with
an induction buffer (IB), haemolytic activity was apparent if the
induction buffer supernatant (IBS) was combined with inducer
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Figure 2. LIPI-3 and corresponding regions in LIPI-3 minus Listeria. Comparison of the LIPI-3-containing region (bottom) with the
corresponding region of LLS
2 L. monocytogenes (middle), L. innocua and L. welshimeri [49]. For L. monocytognes strains, the strain name and serotype
(in brackets) is presented and the designation of the first and last gene in each case is that designated in the corresponding genome sequence.
Homologous genes (or in the case of the llsA-P, clusters of genes) are presented by matching colours.
doi:10.1371/journal.ppat.1000144.g002
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C) and stabiliser (ammonium acetate buffer; AmmAc). Such
haemolytic activity was not induced when F2365LLS
CDhlyDllsB
cells were similarly treated. These investigations provide further
confirmation that LLS is a SLS-like toxin.
Role of LIPI-3 in the virulence of L. monocytogenes F2365
Although it was established that the lls genes encode a cytotoxic
and haemolytic factor, we wanted to assess whether they
contribute to the virulence of L. monocytogenes when under the
control of their native promoter. Given that the importance of SLS
only became apparent upon the analysis of an isogenic mutant [5],
we assessed the contribution of LIPI-3 by comparing the virulence
of wild-type F2365 and F2365DllsB (LLS
2) following intraperito-
neal inoculation of Balb/c mice. From these assays it was apparent
that the LLS
2 strain possessed a reduced virulence potential, as
evidenced by significantly reduced bacterial levels in the livers and
spleens relative to the corresponding wildtype F2365-infected mice
(Fig. 6A). We also investigated if LLS contributes to the survival of
L. monocytogenes in human PMNs. This was prompted by the fact
that firstly, SLS contributes to the ability of GAS to withstand
neutrophil killing [5]; secondly, of all phagocytes, PMNs produce
the greatest concentration of oxidative stress-inducing species (i.e.
those which induce PllsA); and thirdly, the initial response to the
intraperitoneal infection of mice involves an influx of neutrophils.
Notably, PMNs are essential for the resolution of L. monocytogenes
infections, playing a critical role in reducing the bacterial burden
in the liver, spleen and central nervous system [32]. When the
intracellular survival of F2365 and LLS
2 in purified human PMNs
was compared after 2 hrs, it was apparent that wild-type F2365
again survived significantly better than the LLS
2 mutant (Fig. 6B).
Discussion
This study provides new insights into the pathogenesis of several
important Gram positive pathogens. Until recently, modified
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Figure 3. Distribution of LIPI-3 among lineage I L. monocyto-
genes. LIPI-3 status (positive, + or negative, 2) mapped onto a
maximum parsimony tree inferred from sequence data of lineage I
strains (adapted from [24]). The individual sequence types (1–19),
representatives tested (strain number in brackets) and associated
epidemic outbreaks (in red). Strains of serotype 4b and 1/2b are also
distinguished.
doi:10.1371/journal.ppat.1000144.g003
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Figure 4. Haemolytic and cytolytic activities of LLS. (A)
Haemolysis of Columbia blood agar (5% Sheep’s blood) by F2365,
F2365Dhly and F2365DhlyDllsB when the lls genes is under the control
of the natural PllsA or constitutive PHELP promoters (F2365LLS
C,
F2365Lls
CDhly and F2365LLS
CDhlyDllsB). In situations where haemolytic
activity was quantified, the corresponding haemolytic unit (H.U.) values
are presented. (B) Cytotoxicity relative to F2365 (100%) with respect to
the J774, C2-Bbe and CT26 cell lines; F2365Dhly-black, F2365LLS
CDhly-
white. *-significantly different (P,0.05), **-extremely significantly
different (P,0.005) different. Error bars represent standard error of
the mean. (C) Assessment of the haemolytic activity of cell free
supernatant (CFS) of F2365LLS
CDhly and F2365LLS
CDhlyDllsB, of the cell
free supernatant of induction buffer washed F2365LLS
CDhly and
F2365LLS
CDhlyDllsB (IBS), and of IBS from the strains combined with
RNA core (RNA
C; inducer) and ammonium acetate (AmmAc; stabilizer)
aliquoted into 4.6 mm wells in Columbia blood agar (5% Sheep’s
blood). NB. IB, RNA
C and AmmAc, both individually and in combination,
are non-haemolytic (data not shown).
doi:10.1371/journal.ppat.1000144.g004
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cytolysins have been exclusively associated with Streptococcus sp.;
including group A, C and G streptococci and S. iniae (a fish
pathogen) (11). It is now apparent that a number of related gene
clusters can be identified in other Gram positive pathogens,
including L. monocytogenes, S. aureus and C. botulinum. In fact, Lee et
al. have recently reported that in addition to these pathogens,
more distantly related peptides may be produced by microorgan-
isms spanning six phyla [8]. Discovering the role of these
individual peptides, whether it be in conferring antimicrobial (as
with microcin B17) or cytolytic activity (as with SLS) or even
secondary metabolism/morphogenesis [33] now becomes the next
big challenge. With respect to the clusters that most closely
resemble that responsible for SLS production, while the
functionality of the S. aureus and C. botulinum gene clusters has
yet to be confirmed (although in the latter case in vitro production
of modified peptide confirms its haemolytic nature [8]), our
analysis of LIPI-3 and LLS establishes definitively the existence of
an extended family of SLS-like modified virulence peptides
(MVPs), which contribute to the general virulence of the
producing strains and which specifically aids survival following
exposure to PMNs. The association of one such MVP with
selected strains of lineage I L. monocytogenes may provide an insight
into a biologically interesting conundrum associated with this
species. Since it was first established that hly mutants of L.
monocytogenes did not haemolyse blood [34], it has been assumed
that Listeriolysin O is the sole haemolysin/cytolysin produced by
the pathogen. It is now apparent that the absence of LIPI-3 from
many strains, including the majority of the most frequently used
laboratory strains, coupled with the inducible nature of PllsA, has
masked the existence of this second haemolysin/cytolysin.
When one considers their prevalence in animal listeriosis and
food contamination isolates, it is apparent that lineage I isolates
are overrepresented in human listeriosis cases [19,35]. However
no genetic basis has been suggested which could explain the
association between lineage I L. monocytogenes and an increased risk
of human disease. Efforts to identify an elusive lineage I-specific
virulence factor have had to accommodate the fact that such a
factor, if it exists, is not a pre-requisite for pathogenesis but would
simply confer a higher virulence potential in humans (although
perhaps not in animal models of infection). It is tantalising in this
regard that genome analyses revealed very few differences between
epidemic-associated strains and their non-epidemic associated
counterparts. This was first suggested by a genome subtraction
study which identified only 39 gene fragments that are present in
strain F4565 (4b) but absent from EGD (1/2a) [36]. Our re-
examination of these fragments now indicates that three of these
4b specific fragments correspond to regions within LIPI-3.
Similarly, following sequencing of the first four L. monocytogenes
genomes, only 51 serotype 4b-specific genes were identified [21].
Seven of these (plus the previously unannotated llsA) are within
LIPI-3. However, the homologies between these genes and those
involved in SLS biosynthesis have until recently gone unnoticed.
This study confirms that these genes encode a haemolytic/
cytolytic factor which impacts on virulence potential, and also
provide further clarity with respect to their distribution. It is
apparent that LIPI-3 is not specific to serotype 4b, but is associated
with a subset of lineage I isolates. This distribution pattern is
intriguing and strongly implicates this novel haemolysin as a
probable candidate for the elusive virulence factor responsible for
the association of lineage I strains with spontaneous and epidemic
listeriosis outbreaks. We accept that not all cases of listeriosis are
associated with LIPI-3
+ lineage I strains and that a small number
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2 strains have also been linked to epidemic
listeriosis. This probably reflects the likelihood that any L.
monocytogenes strain, regardless of the presence or absence of
LIPI-3, can cause illness if consumed in sufficient quantities by
immunocompromised individuals. Other factors, such as altered
expression of other virulence genes [37], may also explain why
serotype 4d and 4e strains are not routinely associated with human
listeriosis despite, in some cases, possessing LIPI-3. Therefore,
while we suggest that LIPI-3 is the best candidate to date to
explain the greater association of lineage I with human listeriosis,
we anticipate that this hypothesis will no doubt be subjected to
rigorous examination by other researchers in the field. It is also
anticipated that future studies will reveal the precise mechanism
via which LLS contributes to virulence. Given the oxidative-stress
inducible nature of PllsA and the contribution of the peptide to
neutrophil survival, a role in enabling the survival of any cells still
retained in the phagosome upon phago-lysosomal fusion seems the
most likely role. Regardless of the outcome of any such
assessments, the identification of LIPI-3 and Listeriolysin S is a
significant advance in the biology of this important pathogen in
that it represents the first pathogenicity island to be associated with
this notorious lineage of L. monocytogenes.
Materials and Methods
Growth conditions
Listeria were grown in brain heart infusion (BHI) broth or agar
(Oxoid) or Columbia blood agar plates (containing 5% sheep
blood; LIP diagnostics, Galway, Ireland) at 37uC unless otherwise
stated. Strains used are listed in Tables S2 and S3. Escherichia coli
EC101 [38] and TOP10 (Invitrogen) were used as intermediate
vector hosts. Antibiotics were incorporated as follows: Erythro-
mycin [39], 150 mg/ml E. coli,5mg/ml L. monocytogenes; Chlor-
amphenicol (cm), 10 mg/ml E. coli and L. monocytogenes; Kanamycin
(kan) 50 mg/ml E. coli,2 5mg/ml L. monocytogenes; Ampicillin (amp)
100 mg/ml E. coli. 5-bromo-4-chloro-3-indolyl-b-D-galactopyra-
noside (X-Gal) was incorporated when required at a concentration
of 40 mg/ml.
Strain variation studies
For strains of unknown lineage, lineage was determined by an
allele-specific oligonucleotide PCR multiplex as described previ-
ously [24]. The LLS status of strains was determined and
confirmed through three distinct PCR reactions involving the
primer pairs 1118f–1118r (all primers are listed 59 to 39;
TCTTACCCTATTATGAAGTATCA, TAACACCATATCC-
ACTTAAATG), 1118degf–1118degr (GATATGTAACTAG-
CGC TGTATCAACNGGNACNGCT, CCCTCCATACCAC-
CATAAATTAAAKGARTCDATYTG) and llsAint-llsAsoeD
(TGCAGCTGGATGTTGCTC, TAGCCCGGGCAGAACTA-
AAGT). Amplifications were performed in 50 ml volumes with
150 ng/ml concentrations of each primer, 2 mM MgCl2, 0.2 mM
concentrations of each deoxynucleotide triphosphate, 0.5 U of
Taq Polymerase, and 100 ng of genomic DNA. Amplifications
consisted of 30 cycles of 1 min at 94uC, 1 min at 56uC, and 1 min
at 72uC. Amplification products were resolved on 1.5% (wt/vol)
agarose gel.
Genomic dissimilarity
Compositional bias of dinucleotide frequency analysis using the
web-based application deltarho (http://deltarho.amc.uva.nl) [40].
Deltarho calculates the genomic dissimilarity values d_ (the
average dinucleotide relative abundance difference) between input
sequences and the genome sequence of choice [40]. A high
genomic dissimilarity (d_) between an input sequence and the
corresponding host genome sequence indicates a heterologous
origin of the input sequence.
Investigation of PllsA expression with a luciferase-based
reporter system
The promoter reporter vector pPLK2-lux was generated by
amplifying the kanamycin resistance cassette from pTV1-OK [41]
with the primer pair KanRF-KanRR (CCCTGCAGGTCGA-
TAAACC, ACGAATTCCTCGTAGGCGC) and the introduc-
tion of the PstI-EcoRI digested product into similarly-digested
pPL2-lux [42]. PllsA was fused with the lux cassette within
pPLK2-lux through amplification with PllsAfor-PllsAbluntrev
(ATTCGTCGACTTTTGATGCTTAAG, CATTCAAATGCC-
TCCTTTTTATTT) and cloning into the SalI-SwaI sites. The
resultant plasmid was isolated from the intermediate host and
introduced into F2365. Bioluminescence was investigated by
washing overnight cultures and resuspending in an equivalent
volume of spent BHI or BHI containing cumene hydrogen
peroxide (13 mM) or hydrogen peroxide (22 or 50 mM) and
quantified with a Xenogen IVIS 100 imager (Xenogen, Alameda,
CA) with a 5 min exposure time.
Constitutive expression of LLS
To place the lls genes under the control of the strong
constitutive synthetic promoter PHELP,P HELP DNA was amplified
with the primer pair PHELPFsoe-PHELPRsoe (GTGGAGT-
GAAATATAAGTTAGAGG, TCGAGATCTGC AGAT-
GATTGTGATTTAATATTCATGGGTTTCACTCTC) from
plasmid pPL2luxPhelp [29] and fused between two DNA
fragments amplified from the regions flanking PllsA with the
primer pairs PllsAchangeA-PllsAchangeB (ACCTGCA-
GAAGGGGTTATTGA, CTCTAACTTATATTTCACTC-
CAC) and PllsAchangeC-PllsAchangeD (ATGAATATTAAAT-
CACAATCATC, TGGAATTCCCAGCTCCATTGTCTC) by
SOE (splicing by overlap extension) PCR [43] and cloned into the
RepA- shuttle vector pORI280 [44] in the intermediate RepA+
host, Escherichia coli EC101 [38]. The resultant pORI280-help
vector was introduced into F2365 already containing the RepA+,
temperature sensitive helper plasmid pVE6007 [45]. Successfully
transformed cells appeared as blue colonies following plating on
BHI-Ery-Xgal agar at 30uC. To select for integrants, i.e. cells in
which the pORI280-help vector had integrated into the F2365
genome by single crossover homologous recombination, F2365
pVE6007 pORI280-help was grown in BHI-Ery at 30uC,
subcultured twice (0.1% inoculum) in BHI-Ery at 42uC and
streaked onto BHI-Ery-Xgal at 42uC. The introduction of PHELP
upstream of llsA in Ery
R/Cm
S colonies was confirmed by PCR.
Deletion mutagenesis by double crossover homologous
recombination
The hly gene of F2365 was deleted through the amplification
(using the primer pairs hlysoeA-soeB (TGGAATTCCACC-
TAATGGGAAAGT, GGGTTTCACTCTCCTTCTACA) and
hlysoeC-soeD (TGTAGAAGGAGAGTGAAACCCTAGTGTA-
GATAATCC, AAGCCCGGGACAACTAATC-TGAC), splicing
and cloning (into the temperature sensitive shuttle vector pKSV7
[46]) of DNA flanking the gene followed by the introduction of the
spliced product through double crossover homologous recombi-
nation as described previously [47]. This strategy in combination
with the primer pairs, llsBsoeA-soeB (ATTCTAGACAAGGTA-
TAGAAAGG, TTTGCTGTTTCCTTTCTATGTCTG) and
llsBsoeC-soeD (CAGACATAGAAAGGAAAC-AGCAAACAAA-
A Novel L. monocytogenes Haemolysin
PLoS Pathogens | www.plospathogens.org 7 September 2008 | Volume 4 | Issue 9 | e1000144TATTTGTG, TCTCCCGGGAAATAGCTCTTCAC) was also
utilized to delete llsB from F2365 and F2365Lls
CDhly.
Haemolytic assays
Haemolysis was assessed by spotting 10 ml of overnight cultures
onto Columbia blood agar plates and incubating for 24 hr at
37uC. Haemolytic titre assays were carried out as described by
Ginsburg et al (Ginsburg et al. JEM 1965), with some minor
modification. Washed Listeria were concentrated 10 fold i.e. to
2610
10 cfu/ml and serially diluted (twofold) in a volume of 0.3 ml
of activation buffer (0.005 M maltose, 0.001 M MgSO4-7H2O,
0.001 M cysteine) and incubated for 10 min at 37uC. ). 0.5 ml of
prewarmed sheep’s red blood cells (0.2% in activation buffer) was
added and the final volume adjusted to 1.0 ml. The tubes were
incubated at 37uC for 4 hr, centrifuged and haemolysis was
assessed spectrophotometrically with a Softmax Pro spectropho-
tometer (Molecular Devices) at 420 nm. Haemolytic units were
calculated for each strain by taking the inverse of the last dilution
to show complete haemolysis.
Cytotoxicity assays
C2Bbe1 (ATCC CRC-2102), J774 (ATCC TIB-67) and CT26
(ATCC CRL-2638) cells were used for cytotoxicity assays. Cells
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) containing 4.5 g/liter Glutamax (Gibco Laboratories,
Grand Island, NY) and 10% fetal bovine serum (Gibco) at 37uCi n
a5 %C O 2 atmosphere. C2Bbe1 growth media also contained 1%
(vol/vol) nonessential amino acids (Gibco) and 0.01 mg/ml
human transferrin (Calbiochem). In advance of assays cells were
trypsinized (C2Bbe1 and CT26; Gibco) or scraped (J774),
harvested by centrifugation at 4006g for 8 min, and resuspended
in media. Cells were seeded onto 24-well flat-bottom tissue culture
plates (Sarstedt, Leicester, United Kingdom) at a concentration of
3610
5 cells per well. The plates were incubated for approximately
72 h at 37uC in a 5% CO2 atmosphere until confluence was
reached. Overnight cultures of L. monocytogenes were washed and
added at a ratio of 100 bacteria:cell, and the plates were incubated
at 37uC in a 5% CO2 atmosphere for 6 hrs at which time cell-free
supernatant was collected and cytoxicity assayed with the Cytotox
96 Non-Radioactive cytotoxicity assay (Promega, Madison, WI)
according to the kit instructions.
Partial purification and induction of cell-free LLS
Partial purification of LLS was carried out as described by Alouf
and Loridan [31]. Briefly, F2365LLS
CDhly was grown overnight at
37uC in BHI supplemented with maltose (1% w/v) and sodium
bicarbonate (2% w/v; BHI-BM). 50 ml of this culture was
inoculated in 2.5 l BHI-BM and grown at 37uC for 5 hr. The
culture was centrifuged, the cell free supernatant (CFS) collected
for assessment. The cell pellet was washed in 100 mM potassium
phosphate buffer pH 7 before resuspension to a final volume of
40 ml in induction buffer (IB; 100 mM KH2PO4, 2 mM MgSO4,
30 mM maltose (pH 7)). A 1 ml volume of this cell suspension was
centrifuged and the cell free supernatant (IBS) was also collected
for assessment. The remaining 39 ml volume of cell suspension
was incubated at 37uC for 5 min before being induced through the
addition of 0.5 mg yeast RNA core (RNA
C; Sigma)/ml of
suspension and immediately centrifuged. The supernatant was
collected and supplemented with ammonium acetate (AmmAc;
100 mM, pH 7) (IBS+RNA
C+AmmAc). Haemolytic activity was
assessed through the creation of wells (4.6 mm diameter) were in
Columbia blood agar plates (5% sheep’s blood) and the
introduction of 50 ml volumes of the liquid to be assessed. Plates
were incubated overnight at 37uC.
Murine virulence assay
Groups (N=5) of 15-week-old BALB/c mice were inoculated
intraperitoneally with overnight cultures of F2365 or F2365DllsB
resuspended in 0.2 ml of phosphate-buffered saline to a final
concentration of 2610
6 CFU/ml. Mice were sacrificed 3 days
postinfection, and the numbers of L. monocytogenes in the livers and
spleens of infected animals were determined by plating serial 10-
fold dilutions of organ homogenates on BHI agar. All procedures
involving the use of animals were approved by the institutional
animal care committee and complied with relevant legal
guidelines.
Isolation of human PMNs
Polymorphonuclear neutrophil granulocytes (PMNs) were
isolated by a one step procedure based on a method described
by English and Andersen [48]. Briefly, 9 ml EDTA anticoagulated
peripheral blood obtained from healthy donors was diluted with
an equal volume of 0.9% NaCl and carefully overlain on a
discontinuous double gradient formed by layering 4 ml of
polysucrose/sodium diatrizoate adjusted to a density of 1.077 g/
ml (Histopaque 1077) on 4 ml Histopaque 1119 in 15 ml conical
centrifuge tubes (Starstedt UK). The tubes were subsequently
centrifuged at 7006g for 30 min at room temperature. After
centrifugation two distinct leukocyte cell layers (lymphocytes/
monocytes and PMNs, respectively) were obtained above the
bottom sediment of erythrocytes. The PMN layer was carefully
aspirated and washed in DMEM supplemented with 10% fetal calf
serum (DMEM-FCS). Centrifugation followed at 3006g for
10 min at room temperature. After two further washes the cells
were counted using trypan blue staining solution (Sigma-Aldrich
Chemie, Deisenhofen, Germany) and the viability of the cells was
confirmed to be above 97%.
Quantification of intracellular survival of L.
monocytogenes in human PMNs
Human PMNs were isolated as described above and were
adjusted to a final concentration of 1610
6 cells/ml in DMEM-
FCS. Overnight cultures of L. monocytogenes were washed with PBS,
and resuspended in DMEM-FCS at a final concentration of
2610
7/mL. PMNs and L. monocytogenes were combined to yield a
final bacteria:PMN ratio of 20:1. Incubation was at 37uCi n5 %
CO2. After 30 mins the PMNs were washed, resuspended in fresh
medium containing 50 mg/ml of gentamicin (Sigma) to kill
extracellular bacteria, and further incubated until T=2 hrs.
Subsequently, the samples were washed with PBS, and cells were
lysed by the addition of ice-cold water, serially diluted in PBS, and
plated on BHI agar to determine the number of viable
intracellular bacteria.
Statistical analysis
In all cases the differences in mean values were analysed with an
independent samples t-test, following testing for conformity of data
to assumptions of parametric statistics (Kolmogorov-Smirnov test
for normality and Levene’s test for equality of variances).
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